LPA and metabolic dysfunction-associated steatotic liver disease: In contrast, Lp(a) levels are reduced in liver diseases in parallel with liver disease progression, although population studies have yielded conflicting results on the associations between Lp(a) levels and nonalcoholic fatty liver disease.